Skip to main content
Latest news
Browse specialties
Breast cancer Genitourinary cancers Lung & thoracic cancers
In focus
Next-generation sequencing: Emerging biomarkers in thyroid and NSCLCs ctDNA and bladder cancer: Current understanding and beyond ROS1 fusion-positive NSCLC NSCLC driver mutations: Discussing the importance of RET, ALK and ROS1 alterations in NSCLC Early-stage NSCLC management: Surgery, targeted treatment and immunotherapy ALK fusion-positive NSCLC: International approaches to management RET fusion-positive NSCLC: Informing on the use of pralsetinib for patients with RET fusion-positive, advanced NSCLC COVID-19 & cancer
Conferences
SABCS 2022 ESMO 2022 2022 ASCO Annual Meeting
About us
Medicine Matters Oncology
EXTENDED SEARCH

03-06-2018 | Head and neck cancers | ASCO 2018 | Video

Expert commentary: Are women with head and neck cancer undertreated?

ASCO expert Joshua Jones comments on the outcomes of an analysis of cancer registry data from a California Hospital system that highlights a disparity in intensive treatment between men and women with head and neck cancer (2:57).

Read the accompanying news story here.

More on this topic

02-06-2018 | Head and neck cancers | ASCO 2018 | News

Disparity by sex may exist for head and neck cancer treatment, outcomes in USA
Image Credits